FR2938338B1 - Modulateurs de l'acetyl-coenzyme a acyltransferase 1 ou 2 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee - Google Patents

Modulateurs de l'acetyl-coenzyme a acyltransferase 1 ou 2 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee

Info

Publication number
FR2938338B1
FR2938338B1 FR0857709A FR0857709A FR2938338B1 FR 2938338 B1 FR2938338 B1 FR 2938338B1 FR 0857709 A FR0857709 A FR 0857709A FR 0857709 A FR0857709 A FR 0857709A FR 2938338 B1 FR2938338 B1 FR 2938338B1
Authority
FR
France
Prior art keywords
hyperseborrhea
acyltransferase
coenzyme
acne
modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0857709A
Other languages
English (en)
Other versions
FR2938338A1 (fr
Inventor
Michel Rivier
Jerome Aubert
Johannes Voegel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0857709A priority Critical patent/FR2938338B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to RU2010150101/15A priority patent/RU2010150101A/ru
Priority to CA2722556A priority patent/CA2722556A1/fr
Priority to EP09742129A priority patent/EP2286242A1/fr
Priority to PCT/EP2009/055556 priority patent/WO2009135911A1/fr
Priority to US12/991,060 priority patent/US20110150773A1/en
Priority to MX2010011730A priority patent/MX2010011730A/es
Priority to JP2011507928A priority patent/JP2011523548A/ja
Publication of FR2938338A1 publication Critical patent/FR2938338A1/fr
Application granted granted Critical
Publication of FR2938338B1 publication Critical patent/FR2938338B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91051—Acyltransferases other than aminoacyltransferases (general) (2.3.1)
    • G01N2333/91057—Acyltransferases other than aminoacyltransferases (general) (2.3.1) with definite EC number (2.3.1.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
FR0857709A 2008-05-07 2008-11-13 Modulateurs de l'acetyl-coenzyme a acyltransferase 1 ou 2 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee Expired - Fee Related FR2938338B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0857709A FR2938338B1 (fr) 2008-11-13 2008-11-13 Modulateurs de l'acetyl-coenzyme a acyltransferase 1 ou 2 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
CA2722556A CA2722556A1 (fr) 2008-05-07 2009-05-07 Modulateurs d'acetyl-coenzyme a acyltransferase 1 ou 2 dans le traitement de l'acne, de dermatite seborrheique ou d'hyperseborrhee
EP09742129A EP2286242A1 (fr) 2008-05-07 2009-05-07 Modulateurs d'acétyl- coenzyme a acyltransférase 1 ou 2 dans le traitement de l'acné, de dermatite séborrhéique ou d'hyperséborrhée
PCT/EP2009/055556 WO2009135911A1 (fr) 2008-05-07 2009-05-07 Modulateurs d'acétyl- coenzyme a acyltransférase 1 ou 2 dans le traitement de l'acné, de dermatite séborrhéique ou d'hyperséborrhée
RU2010150101/15A RU2010150101A (ru) 2008-05-07 2009-05-07 Модуляторы ацетилкоэнзим-а-ацилтрансферазы 1 или 2 в лечении акне, себорейного дерматита или гиперсебореи
US12/991,060 US20110150773A1 (en) 2008-05-07 2009-05-07 Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
MX2010011730A MX2010011730A (es) 2008-05-07 2009-05-07 Moduladores de acetil-coenzima a aciltransferasa 1 o 2 en el tratamiento de acne, de dermatitis seborreica o de hiperseborrea.
JP2011507928A JP2011523548A (ja) 2008-05-07 2009-05-07 ざ瘡、脂漏性皮膚炎、または皮脂分泌過多の治療におけるアセチルＣｏＡアシルトランスフェラーゼ１またはアセチルＣｏＡアシルトランスフェラーゼ２の調節剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0857709A FR2938338B1 (fr) 2008-11-13 2008-11-13 Modulateurs de l'acetyl-coenzyme a acyltransferase 1 ou 2 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee

Publications (2)

Publication Number Publication Date
FR2938338A1 FR2938338A1 (fr) 2010-05-14
FR2938338B1 true FR2938338B1 (fr) 2012-10-05

Family

ID=40825204

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0857709A Expired - Fee Related FR2938338B1 (fr) 2008-05-07 2008-11-13 Modulateurs de l'acetyl-coenzyme a acyltransferase 1 ou 2 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee

Country Status (8)

Country Link
US (1) US20110150773A1 (fr)
EP (1) EP2286242A1 (fr)
JP (1) JP2011523548A (fr)
CA (1) CA2722556A1 (fr)
FR (1) FR2938338B1 (fr)
MX (1) MX2010011730A (fr)
RU (1) RU2010150101A (fr)
WO (1) WO2009135911A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX364220B (es) 2012-02-09 2019-04-16 Nogra Pharma Ltd Metodos de tratamientos de fibrosis.
JP6529691B2 (ja) * 2017-04-20 2019-06-12 株式会社マンダム 皮脂腺の観察方法
EP3869194B1 (fr) * 2018-10-17 2024-01-10 Mandom Corporation Procédé d'observation de glande sébacée et son utilisation
US20220000818A1 (en) * 2019-01-25 2022-01-06 Nogra Pharma Limited Compositions for use in preventing acne
KR20210125047A (ko) 2019-02-08 2021-10-15 노그라 파마 리미티드 3-(4'-아미노페닐)-2-메톡시프로피온산, 및 그의 유사체 및 중간체의 제조 방법
JP7498738B2 (ja) 2022-03-16 2024-06-12 花王株式会社 皮脂ｒｎａ情報のデータ均質化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1549398A1 (fr) * 2002-09-19 2005-07-06 MediGene Aktiengesellschaft Inhibiteurs de l'oxydation d'acides gras pour la prophylaxie et/ou le traitement de maladies chroniques et/ou atopiques de la peau
FR2862870A1 (fr) * 2003-12-01 2005-06-03 Galderma Res & Dev Utilisation d'activateurs de recepteurs ppar en cosmetique et dermatologie.
US20060100146A1 (en) * 2004-08-16 2006-05-11 Sturley Stephen L AWAT-related methods and articles
FR2903999B1 (fr) * 2006-07-19 2008-09-05 Galderma Res & Dev S N C Snc Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee

Also Published As

Publication number Publication date
EP2286242A1 (fr) 2011-02-23
MX2010011730A (es) 2010-11-25
RU2010150101A (ru) 2012-06-20
WO2009135911A1 (fr) 2009-11-12
FR2938338A1 (fr) 2010-05-14
US20110150773A1 (en) 2011-06-23
JP2011523548A (ja) 2011-08-18
CA2722556A1 (fr) 2009-11-12

Similar Documents

Publication Publication Date Title
FR2938338B1 (fr) Modulateurs de l'acetyl-coenzyme a acyltransferase 1 ou 2 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
BRPI0920104A2 (pt) tratamento de soluções ou de águas residuais
FR2984355B1 (fr) Procede de preparation d'alliage polymere/entites biologiques
IT1404123B1 (it) Macchina per la produzione e l'erogazione di prodotti liquidi, semiliquidi e/o semisolidi.
BRPI0809272A2 (pt) Compostos de biaril e biheteroaril no tratamento de distúrbios do ferro
BRPI0811356A2 (pt) Métodos para determinar a concentração de um polímero ou oligômero aniônicos
BR112014029012A2 (pt) variantes de quimosina com propriedades melhoradas de coagulação do leite
BRPI0808043A2 (pt) Compostos tricíclicos úteis no tratamento de distúrbios de ferro.
FR2968520B1 (fr) Element pour l'application de fibres sur des fibres keratiniques humaines
FR2982156B1 (fr) Composition cosmetique ou dermatologique comprenant un alpha-alcoxysilane obtenu a partir d'un acrylate
FR2935390B1 (fr) Copolymere pour le traitement ou la modification de surfaces
FR2958293B1 (fr) Outils pour l'identification de ligands de lingo-1,lingo-2, lingo-3 et lingo-4, et utilisations
FR2986549B1 (fr) Boite de raccordement ou d'incorporation pour tuyaux encastres
FR2963372B1 (fr) Element prefabrique pour le passage de gaines techniques.
FR2903999B1 (fr) Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
FR2998894B1 (fr) Procede de fractionnement d'algues et utilisation des molecules obtenues
FR2995919B1 (fr) Robinet de reseau d'eau, ensemble de comptage
FR2948816B1 (fr) Dispositifs electro-optiques bases sur la variation d'indice ou d'absorption dans des transitions isb.
FR2964391B1 (fr) Biopuces pour l'analyse de la dynamique de molecules d'acide nucleique
BRPI1009089A2 (pt) "dispositivo de fricção controlada".
FR2903998B1 (fr) Modulateurs de elovl5 dans le traitement de l'acne ou de l'hyperseborrhee
FR2930727B1 (fr) Composition pour le traitement des etats seborrheiques.
FR2939051B1 (fr) Installation de traitement de liquides notamment pour le traitement d'effluents
FR2908134B1 (fr) Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide
FR2954763B1 (fr) Installation pour le traitement d'eaux residuaires.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130731